Prof. Manjul TRIPATHIIndia
POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH, CHANDIGARH
2015-2019 to present | Assistant Professor |
2019-2022 to present | Associate Professor |
2022-Till date to present | Additional Professor |
2010 - 2013 | MCh Neurosurgery |
2006 - 2009 | MS General Surgery |
2000 - 2006 | MBBS |
2013 - 2014 | ICMR Senior Research Officer, AIIMS, New Delhi |
2014 - 2015 | Faculty, Neurosurgery, NIMHANS, Bengaluru |
2017 - 2017 | Fellow, Functional Neurosurgery, OXFORD, UK |
2015 - TILL DATE | Faculty, Neurosurgery, PGIMER, Chandigarh |
Gamma knife neurosurgeon; Skull Base Surgeon; Functional Neurosurgeon; Neurotrauma; Neurooncology
Faculty, Neurosurgery, PGIMER, Chandigarh
In Charge of Radiosurgery & Functional Neurosurgery Services, PGIMER Chandigarh
Executive Committee member and Education Cell/Social media In-charge of Neurological Society of India (NSI),
Secretary: Indian Society of Stereotactic & Functional Neurosurgery (ISSFN)
Section Editor: Neurology India, WFNS Journal, Journal of Postgraduate Medical Education and Research
382 research papers, several awards
Fellow functional neurosurgery, Oxford UK & Skills Training, AIIMS, New Delhi
Areas of interest:
Gamma Knife Radiosurgery
Functional Neurosurgery
Neurotrauma
Neuro oncology
Art and Science
Author of book “Krodh” with Antonio de Sales
Renaissance in radio surgical lesioning: A new era on horizon
1110 11:00-11:10
Functional Neurosurgery & Epilepsy/304A
Current medical education is evidence based. However, the pieces of evidence are frequently morphed in the scientific world due to various inherent biases and hidden motives. Radiosurgery has entered in a new age of renaissance thanks to improved technology, radiological advancements and the cross training with contemporary experience in stimulation and radiofrequency targeting. Radio surgical influence in functional radiosurgery ranges from necrotic, subnecrotic to neuromodulatory influence. With a keen interest and experience in functional radiosurgery, author presents his experience and recommendations on the controversial issues of psycho-radiosurgery, pallidotomy, thalamotomy, subthalamotomy, and epilepsy surgery. The science of lesioning is dying. Even many established functional neurosurgery centers do not have neurosurgeons experienced in lesioning, or they will be retiring soon. With them, the art of lesioning is also going to die, and any further training would remain insufficient. In the absence of industrial support, promotion, advertisement, and lack of teachers, lesioning will soon come an “orphan procedure” akin to many “orphan drugs.” It is time to candidly accept the limitations of DBS and the need of an alternative/rescue procedure, which is equally sound with its own set of indications. We cannot rule out the role of industries in promoting science and help in new discoveries but the time-honored cost-effective procedures should not be killed for the sake of financial gains. Researchers and practitioners need to be unbiased in such situations.
Is surgery a history for skull base paragangliomas?
1108 13:40-13:50
Skull Base/304A
Paragangliomas are benign but confounding pathologies harbored in the skull base, occupying critical locations like the middle ear, jugular foramen and carotid bifurcation. They are highly vascular tumors that commonly present with locally advanced disease, infiltrating lower cranial nerves thereby disparaging the prospect of surgery due to possible complications. Conventional radiotherapy in form of external beam radiotherapy and intensity modulated radiotherapy offered promise for tumor control; however, this was an unacceptable trade-off with the side effects accompanying these modalities. Over the years, stereotactic surgery (SRS) has garnered an unswerving consensus as a standalone and adjunctive therapy for GT. We discuss our philosophy of treating this pathology in the background of our own experience widely published and evolving literature on Gamma Knife surgery for GT. We aim to address diagnostic and therapeutic dilemmas surrounding GT to aid clinicians in decision making.